2-(2,4-Bis(trifluoromethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 1g

4-Methyl-3-(piperidine-1-sulfonyl)benzoic acid, 95.0%, 1g

Sulfuric acid D2 98% solution in D2O, 99.5 at%D, 10 ml, glass packaging

myo-Inositol, 98.00%, 5g

PYROXAMIDE, 95%, 250mg

Cytosine-b-D-arabinofuranoside hydrochloride, 98.0%, 10g

1-Benzyl-4-hydroxypiperidine, 97.0%, 1g

Pipette tips MIKRO 0.1–10 μl with scale, Box, 960 pieces, Non sterile, 960 pieces

2-Bromo-3-fluorobenzotrifluoride, 98.0%, 100g

Dodecylphosphocholine, 95.0%, 1g

tert-Butyl (4-methylpiperidin-4-yl)carbamate, 95.0%, 25g

2-Oxoimidazolidine-1-carbonyl chloride, 95.0%, 1g

N-[(1,2-Dihydro-6-methyl-2-oxo-4-propyl-3-pyridinyl)methyl]-1-(1-methylethyl)-6-[6-(4-methyl-1-piperazinyl)-3-pyridinyl]-1H-pyrazolo[3,4-b]pyridine-4-carboxamide, 97%, 10mg